Abstract:Background The pathogenesis of nasopharyngeal carcinoma (NPC) is a complicated process involving genetic predisposition, Epstein-Bar Virus infection, and genetic alterations. Although some oncogenes and tumor suppressor genes have been previously reported in NPC, a complete understanding of the pathogenesis of NPC in the context of global gene expression, transcriptional pathways and biomarker assessment remains to be elucidated. Methods Total RNA from 32 pathologically-confirmed cases of poorly-differentiated NPC was divided into pools inclusive of four consecutive specimens and each pool (T1 to T8) was co-hybridized with pooled RNA from 24 normal non-cancerous nasopharyngeal tissues (NP) to a human 8K cDNA array platform. The reliability of microarray data was validated for selected genes by semi-quantitative RT-PCR and immunohistochemistry. Results Stringent statistical filtering parameters identified 435 genes to be up-regulated and 257 genes to be down-regulated in NPC compared to NP. Seven up-regulated genes including CYC1, MIF, LAMB3, TUBB2, UBE2C and TRAP1 had been previously proposed as candidate common cancer biomarkers based on a previous extensive comparison among various cancers and normal tissues which did not, however, include NPC or NP. In addition, nine known oncogenes and tumor suppressor genes, MIF, BIRC5, PTTG1, ATM, FOXO1A, TGFBR2, PRKAR1A, KLF5 and PDCD4 were identified through the microarray literature-based annotation search engine MILANO, suggesting these genes may be specifically involved in the promotion of the malignant conversion of nasopharyngeal epithelium. Finally, we found that these differentially expressed genes were involved in apoptosis, MAPK, VEGF and B cell receptor signaling pathways and other functions associated with cell growth, signal transduction and immune system activation. Conclusion This study identified potential candidate biomarkers, oncogenes/tumor suppressor genes involved in several pathways relevant to the oncogenesis of NPC. This information may facilitate the determination of diagnostic and therapeutic targets for NPC as well as provide insights about the molecular pathogenesis of NPC.

Preparation of Polyclonal Antibody Specific for NOR1 and Detection of Its Expression Pattern in Human Tissues and Nasopharyngeal Carcinoma

Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.

Screen and Identification of the Protein-Protein Interactors of Nor1, A Novel Gene Down-Regulated in Nasopharyngeal Carcinoma

Differential expression of oxidored nitro domain containing protein 1 (NOR1), in mouse tissues and in normal and cancerous human tissues.

Studies of association between nasopharyngeal carcinoma and single-nucleotide polymorphisms in NOR1, a novel oxidored-nitro domain-containing protein gene

Cloning, expression, and mutation analysis of NOR 1 , a novel human gene down-regulated in HNE 1 nasopharyngeal carcinoma cell line

Oxidored-nitro Domain Containing Protein 1 (NOR1) Expression Suppresses Slug/vimentin but Not Snail in Nasopharyngeal Carcinoma: Inhibition of EMT in Vitro and in Vivo in Mice.

NOR1 Regulates Morphogenetic Cell Behavior in vitro Coincident With Inhibition of a Non-canonical Wnt-signaling Cascade

The NOR1/OSCP1 proteins in cancer: From epigenetic silencing to functional characterization of a novel tumor suppressor

NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro.

Oxidored-nitro Domain-Containing Protein 1 Expression is Associated with the Progression of Hepatocellular Carcinoma

[Expression of a New Cloned Nitroreductase Gene NOR1 and Purification of Expressed Product].

Nor1 Suppresses Cancer Stem-Like Cells Properties Of Tumor Cells Via The Inhibition Of The Akt-Gsk-3 Beta-Wnt/Beta-Catenin-Aldh1a1 Signal Circuit

The Tumor Suppressor NOR1 Suppresses Cell Growth, Invasiveness, and Tumorigenicity in Glioma.

Testis Selective Expression of NOR1 Gene in Rat and Down Regulation of NOR1 Protein in Human Testicular Germ Cell Tumors

Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma

Identification and Characterization of a Novel Nasopharyngeal Carcinoma-Associated Peptide: NAP-1

Proliferating Cell Nuclear Antigen (PCNA), Nucleolar Organizer Regions (AgNORs), and Mitotic Indeces in Nasopharyngeal Carcinoma

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Expression of oxidored nitro domain-containing protein 1(NOR1) impairs nasopharyngeal carcinoma cells adaptation to hypoxia and inhibits PDK1 expression